TAGCyx Biotechnologies Overview

  • Founded
  • 2007

Founded
  • Status
  • Private

  • Employees
  • 20

Employees
  • Latest Deal Type
  • Later Stage VC

  • Latest Deal Amount
  • $1.92M

  • Investors
  • 7

TAGCyx Biotechnologies General Information

Description

Developer of a drug discovery platform designed to identify and develop novel nucleic acid-based drugs. The company's platform utilizes genetic alphabet expansion by unnatural base pairs to generate customized nucleic acid suited for therapeutic applications, enabling medical professionals to treat diseases efficiently.

Contact Information

Website
www.tagcyx.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 403 Komaba Open Laboratory, University of Tokyo
  • 4-6-1 Komaba, Meguro-ku
  • Tokyo, Tokyo 153-0041
  • Japan

TAGCyx Biotechnologies Timeline

2019202020212022
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

TAGCyx Biotechnologies Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 02-Jun-2021 $1.92M 000.00 000.00 Completed Generating Revenue
6. Later Stage VC (Series C) 27-Apr-2020 00.00 000.00 000.00 Completed Generating Revenue
5. Later Stage VC (Series B) 24-Apr-2018 00.000 000.00 000.00 Completed Generating Revenue
4. Later Stage VC (Series A) 31-Aug-2016 00.000 00.000 000.00 Completed Generating Revenue
3. Later Stage VC 31-Mar-2016 00000 00.000 Completed Generating Revenue
2. Early Stage VC 30-Dec-2011 $1.67M $2.22M Completed Startup
1. Seed Round 28-Dec-2010 $551K $551K Completed Startup
To view TAGCyx Biotechnologies’s complete valuation and funding history, request access »

TAGCyx Biotechnologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C2 Preferred 0,000 00000.0 00000.0 00 00000.0 0.000
C Preferred 0,000 0000.00 0000.00 00 0000.00 0.000
B Preferred 3,450 $1327.81 $1327.81 1x $1327.81 15.54%
A Preferred 4,167 $1098.88 $1098.88 1x $1098.88 18.77%
To view TAGCyx Biotechnologies’s complete cap table history, request access »

TAGCyx Biotechnologies Patents

TAGCyx Biotechnologies Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
ES-2903041-T3 Dna aptamer capable of binding vwf Active 30-Oct-2015 00000000
JP-6721189-B2 Dna aptamer that binds to vwf Active 30-Oct-2015 00000000
AU-2016346270-A1 Dna aptamer capable of bonding to vwf Pending 30-Oct-2015 00000000
CA-3003576-A1 Dna aptamer that binds to vwf Pending 30-Oct-2015 00000000
EP-3369820-A1 Dna aptamer capable of bonding to vwf Active 30-Oct-2015 A61P7/02
To view TAGCyx Biotechnologies’s complete patent history, request access »

TAGCyx Biotechnologies Executive Team (4)

Name Title Board Seat Contact Info
Chizuko Koseki Ph.D President & Chief Executive Officer
Akiyoshi Kudose Chief Financial Officer & Board Member
Susumu Muto Chief Scientific Officer & Board Member
Akinori Mochizuki Ph.D CBO
To view TAGCyx Biotechnologies’s complete executive team members history, request access »

TAGCyx Biotechnologies Board Members (8)

Name Representing Role Since
Akiyoshi Kudose TAGCyx Biotechnologies Chief Financial Officer & Board Member 000 0000
Junya Yamazaki The University of Tokyo Edge Capital Board Member 000 0000
Katsunori Suzuki Self Board Member 000 0000
Maiko Katadae Ph.D The University of Tokyo Edge Capital Board Member 000 0000
Mikio Kawahara UTokyo Innovation Platform Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

TAGCyx Biotechnologies Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

TAGCyx Biotechnologies Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Healthcare Innovation Venture Capital Minority 000 0000 000000 0
SBI Holdings Venture Capital Minority 000 0000 000000 0
MCP Partners PE/Buyout Minority 000 0000 000000 0
UTokyo Innovation Platform Venture Capital Minority 000 0000 000000 0
Nissay Capital Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »